These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 23442774)

  • 41. Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis.
    Lee S; Choi D; Jeong WK
    J Magn Reson Imaging; 2016 Nov; 44(5):1339-1345. PubMed ID: 27197633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects.
    Lin YH; Hwang RM; Chen BB; Hsu CY; Yu CW; Kao JH; Lee HS; Liang PC; Wei SY; Shih TT
    Clin Imaging; 2014; 38(3):287-91. PubMed ID: 24556332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfecting the multidrug resistance protein 2 gene improves transcellular organic anion transport.
    Itani T; Kobayashi Y; Kuroda M; Ma N; Mifuji R; Urawa N; Tanaka Y; Kaito M; Adachi Y
    Int J Mol Med; 2005 Nov; 16(5):821-5. PubMed ID: 16211250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
    Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.
    Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ
    PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.
    Clemént O; Mühler A; Vexler VS; Kuwatsuru R; Berthezène Y; Rosenau W; Brasch RC
    J Magn Reson Imaging; 1993; 3(1):71-7. PubMed ID: 8428104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired hepatic Gd-EOB-DTPA enhancement after radioembolisation of liver malignancies.
    Powerski MJ; Scheurig-Münkler C; Hamm B; Gebauer B
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):472-80. PubMed ID: 24964737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.
    Stern W; Schick F; Kopp AF; Reimer P; Shamsi K; Claussen CD; Laniado M
    Acta Radiol; 2000 May; 41(3):255-62. PubMed ID: 10866081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease - A biopsy-verified prospective study.
    Norén B; Dahlström N; Forsgren MF; Dahlqvist Leinhard O; Kechagias S; Almer S; Wirell S; Smedby Ö; Lundberg P
    Eur J Radiol Open; 2015; 2():19-25. PubMed ID: 26937432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
    Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
    J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].
    Stroszczynski C; Gaffke G; Gnauck M; Streitparth F; Wieners G; Lopez-Häninnen E
    Radiologe; 2004 Dec; 44(12):1185-91. PubMed ID: 15549226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional magnetic resonance cholangiography enhanced with Gd-EOB-DTPA: effect of liver function on biliary system visualization.
    Feng ST; Wu L; Chan T; Cai H; Luo Y; Zheng K; Tang D; Li ZP
    J Magn Reson Imaging; 2014 May; 39(5):1254-8. PubMed ID: 24115466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
    Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
    Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
    Schmitz SA; Mühler A; Wagner S; Wolf KJ
    Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.
    Tamada T; Ito K; Sone T; Kanki A; Sato T; Higashi H
    Eur J Radiol; 2011 Dec; 80(3):e207-11. PubMed ID: 20869827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Image quality of Gd-EOB-DTPA-enhanced magnetic resonance imaging of the liver using dual-source parallel radiofrequency transmission technology: Comparison with the post-processing correction method for B1 inhomogeneity-induced signal loss.
    Takayama Y; Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Yoshiura T; Obara M; Hirakawa M; Honda H
    Eur J Radiol; 2012 Nov; 81(11):3035-40. PubMed ID: 22578836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.